BioSpace News Archive

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the World Intellectual Property Organization has published a patent application filed under the Patent Cooperation Treaty covering TNX-1500, a humanized monoclonal antibody (mAb) directed against CD40-ligand,

TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020. Preliminary Unaudited Fourth Quarter and Full Year Results: Fourth quarter revenue is expec

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to OTL-200,

Boston Scientific (NYSE: BSX) has announced a limited market release of the WaveWriter Alpha ™ portfolio of Spinal Cord Stimulator (SCS) systems.

Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension (XR-NTX) administered once every three weeks plus oral extended-release bupropion administered daily as a combination treatment for adults with moderate or severe methamphetamine

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough and other hypersensitization-related disorders, today announced that Dr. Catherine Bonuccelli, M.D., BELLUS Health’s Chief Medical Officer, and Dr. Denis Garceau, Ph.D., Bellus Health’s Senior Vice President of Drug Development, w

According to the research report published by Fact.MR accessories & consumables, and auto-samplers are expected to emerge as the fastest-selling products in the global gas chromatography market.

The global medical education market is projected to drive on account of surging need to treat chronic ailments together with incessantly growing population all over the world.

Coma is a condition, wherein the affected person is unconscious, unresponsive to stimuli, and cannot be woken. The condition primarily affects the brain and results from brain stroke or traumatic brain injuries.

DNA damage is an abnormal structure in DNA that leads to change in structure of genetic material and prevents the replication mechanism from functioning and performing properly.